Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX) SEC filings
Insight Molecular Diagnostics Inc. (IMDX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported IMDX revenue for 2025-09-30 was $260.0K. Net income was -$10.9M. Revenue was down 49.8% from 2025-06-30 to 2025-09-30. The IMDX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Insight Molecular Diagnostics Inc. said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
0
8-K
0
Form 4
No cached SEC filings for IMDX yet. When an 8-K lands, this page will show the exhibit headline and numbers.
Open EDGAREDGAR is the official archive. Browse all IMDX filings.
Frequently asked questions
What did IMDX just say?
IMDX cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are IMDX SEC filings?
0 cached filings are on this page. EDGAR remains the official archive.
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.